Applications for a-lactalbumin in human nutrition

Nutrition Reviews

Volumn 76, Issue 6, 2018, Pages 444-460

  Layman, Donald K ^c   Lönnerdal, Bo ^a   Fernstrom, John D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c 260 Bevier Hall ^*  (United States)

Author keywords

Infant formula; Leucine; Serotonin; Sleep; Tryptophan

Indexed keywords

ALPHA LACTALBUMIN; BRANCHED CHAIN AMINO ACID; CYSTEINE; TRYPTOPHAN; AMINO ACID; ESSENTIAL AMINO ACID; LACTALBUMIN;

ARTIFICIAL MILK; BRAIN FUNCTION; BREAST MILK; CANCER THERAPY; DEPRESSION; EPILEPSY; HUMAN; INFANT NUTRITION; MALIGNANT NEOPLASM; MOOD; MOOD DISORDER; MUSCLE METABOLISM; NUTRITION; OXIDATIVE STRESS; REVIEW; SARCOPENIA; SEIZURE; SKELETAL MUSCLE; SLEEP; SLEEP WAKING CYCLE; TRYPTOPHAN BRAIN LEVEL; ADULT; ANIMAL; BOVINE; CHEMISTRY; CHILD DEVELOPMENT; DIETARY SUPPLEMENT; DRUG EFFECT; FEMALE; INFANT; MALE; NUTRITIONAL STATUS;

ADULT; AMINO ACIDS; AMINO ACIDS, ESSENTIAL; ANIMALS; CATTLE; CHILD DEVELOPMENT; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; LACTALBUMIN; MALE; MILK, HUMAN; NUTRITIONAL STATUS;

EID: 85054474361     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuy004     Document Type: Review

References (178)

1. Heine WE, Klein PD, Reeds PJ. The importance of a-lactalbumin in infant nutrition. J Nutr. 1991;121:277-283.
2. Kunz C, Lönnerdal B. Re-evaluation of the whey protein/casein ratio of human milk. Acta Paediatr. 1992;81:107-112.
3. Krissansen GW. Emerging health properties of whey proteins and their clinical implications. J Am Coll Nutr. 2007;26:713S-723S.
4. US Department of Agriculture, Agriculture Research Service. USDA Food Composition Database. Beltsville, MD: Nutrient Data Laboratory; 2015. https://ndb.nal.usda.gov/ndb/. Slightly revised May 2016. Accessed February 28, 2018.
5. Atkinson SA, Lönnerdal B. Nitrogenous components of milk. In: Handbook of Milk Composition. In: Jensen RG, ed. San Diego, CA: Academic Press; 1995:351-387.
6. Swaisgood HE. Protein and amino acid composition of bovine milk. In: Jensen RG, ed. Handbook of Milk Composition. San Diego, CA: Academic Press; 1995:464-467.
7. Kamau SM, Cheison SC, Chen W, et al. Alpha-lactalbumin: its production technologies and bioactive peptides. Comp Rev Food Sci. 2010;9:197-212.
8. Morr CV, Ha EY. Whey protein concentrates and isolates: processing and functional properties. Crit Rev Food Sci Nutr. 1993;33:431-476.
9. Permyakov EA, Berliner LJ. a-Lactalbumin: structure and function. FEBS Lett. 2000;473:269-274.
10. Lien EL. Infant formulas with increased concentrations of alpha-lactalbumin. Am J Clin Nutr. 2003;77:1555S-1558S.
11. Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr. 2014;99:712S-717S.
12. US Food and Drug Administration. Infant formula. 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr¼107.100. Accessed February 28, 2018.
13. Food and Agriculture Organization of the United Nations. Revised standard for infant formula and formulas for special medical purposes intended for infants. Codex Stan 72-1981. In: Codex Alimentarius. Rome, Italy: Food and Agriculture Organization of the United Nations; Revision 2007.
14. Rudloff S, Kunz C. Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: quantitative and qualitative aspects in infant nutrition. J Pediatr Gastroenterol Nutr. 1997;24:328-344.
15. Rcaihca NC, Axelsson IE. Protein nutrition during infancy. An update. Pediatr Clin North Am. 1995;42:745-764.
16. Koletzko B, von Kries R, Closa R, et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr. 2009;89:1836-1845.
17. Trabulsi J, Capeding R, Lebumfacil J, et al. Effect of an a-lactalbumin-enriched infant formula with lower protein on growth. Eur J Clin Nutr. 2011;65:167-174.
18. Lönnerdal B, Lien EL. Nutritional and physiologic significance of alpha-lactalbumin in infants. Nutr Rev. 2003;61:295-305.
19. Bagdy G, Kecskemeti V, Riba P, et al. Serotonin and epilepsy. J Neurochem. 2007;100:857-873.
20. Lien EL, Davis AM, Euler AR, et al. Growth and safety in term infants fed reduced-protein formula with added bovine alpha-lactalbumin. J Pediatr Gastroenterol Nutr. 2004;38:170-176.
21. Sandström O, Lönnerdal B, Graverholt G, et al. Effects of a-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am J Clin Nutr. 2008;87:921-928.
22. Mirmiran M, Van Someren E. Symposium: normal and abnormal REM sleep regulation: the importance of REM sleep for brain maturation. J Sleep Res. 1993;2:188-192.
23. Steinberg LA, O'Connell NC, Hatch TF, et al. Tryptophan intake influences infants' sleep latency. J Nutr. 1992;122:1781-1791.
24. Fernstrom JD. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev. 1983;63:484-546.
25. Huether G, Poeggeler B, Reimer A, et al. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci. 1992;51:945-953.
26. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 1998;78:687-721.
27. Heine WE. The significance of tryptophan in infant nutrition. Adv Exp Med Biol. 1999;467:705-710.
28. Cubero J, Valero V, Sanchez J, et al. The circadian rhythm of tryptophan in breast milk affects the rhythms of 6-sulfatoxymelatonin and sleep in newborn. Neuro Endocrinol Lett. 2005;26:657-661.
29. Pardridge WM. The role of blood-brain barrier transport of tryptophan and other neutral amino acids in the regulation of substrate-limited pathways of brain amino acid metabolism. J Neural Transm Suppl. 1979;15:43-54.
30. Fernstrom JD, Langham KA, Marcelino LM, et al. The ingestion of different dietary proteins by humans induces large changes in the plasma tryptophan ratio, a predictor of brain tryptophan uptake and serotonin synthesis. Clin Nutr. 2013;32:1073-1076.
31. Yogman MW, Zeisel SH. Diet and sleep patterns in newborn infants. N Engl J Med. 1983;309:1147-1149.
32. Aparicio S, Garau C, Esteban S, et al. Chrononutrition: use of dissociated day/ night infant milk formulas to improve the development of the wake-sleep rhythms. Effects of tryptophan. Nutr Neurosci. 2007;10:137-143.
33. Esteban S, Nicolaus C, Garmundi A, et al. Effect of orally administered L-tryptophan on serotonin, melatonin, and the innate immune response in the rat. Mol Cell Biochem. 2004;267:39-46.
34. Yogman MW, Zeisel SH, Roberts C. Assessing effects of serotonin precursors on newborn behavior. J Psychiatr Res. 1982;17:123-133.
35. Andreas NJ, Kampmann B, Mehring Le-Doare K. Human breast milk: a review on its composition and bioactivity. Early Human Dev. 2015;91:629-635.
36. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 2007;61:2-8.
37. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77:1537S-1543S.
38. Pellegrini A, Thomas U, Bramaz N, et al. Isolation and identification of three bactericidal domains in the bovine a-lactalbumin molecule. Biochim Biophys Acta. 1999;1426:439-448.
39. Giuffrida MG, Cavaletto M, Ciunta C, et al. The unusual amino acid triplet Asn-Ile-Cys is a glycosylation consensus site in human a-lactalbumin. J Protein Chem. 1997;16:747-753.
40. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366.
41. Wu G. Synthesis of amino acids. In: Amino Acids: Biochemistry and Nutrition. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2013:63-96.
42. Keszthelyi D, Troost FJ, Masclee AAM. Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol Motil. 2009;21:1239-1249.
43. Madureira AR, Tavares T, Gomes AM, et al. Invited review: physiological properties of bioactive peptides obtained from whey proteins. J Dairy Sci. 2010;93:437-455.
44. Yuwiler A, Brammer GL, Morley JE, et al. Short-term and repetitive administration of oral tryptophan in normal men: effects on blood tryptophan, serotonin, and kynurenine concentrations. Arch Gen Psychiatry. 1981;38:619-626.
45. Migliore-Samour D, Roch-Arveiller M, Tissot M, et al. Effects of tripeptides derived from milk proteins on polymorphonuclear oxidative and phosphoinositide metabolisms. Biochem Pharmacol. 1992;44:673-680.
46. Dupont C, Rivero M, Grillon C, et al. a-Lactalbumin-enriched and probiotic-supplemented infant formula in infants with colic: growth and gastrointestinal tolerance. Eur J Clin Nutr. 2010;64:765-767.
47. Ushida Y, Shimokawa Y, Matsumoto H, et al. Effects of bovine a-lactalbumin on gastric defense mechanisms in naïve rats. Biosci Biotechnol Biochem. 2003;67:577-583.
48. Kamau SM, Cheison SC, Chen W, et al. Alpha-lactalbumin: its production technologies and bioactive peptides. Comp Rev Food Sci Food Safey. 2010;9:197-212.
49. Berthou J, Migliore-Samour D, Lifchitz A, et al. Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins. FEBS Lett. 1987;218:55-58.
50. Jaziri M, Migliore-Samour D, Casabianca-Pignede MR, et al. Specific binding sites on human phagocytic blood cells for Gly-Leu-Phe and Val-Glu-Pro-Ile-Pro-Tyr, immunostimulating peptides from human milk proteins. Biochim Biophys Acta. 1992;1160:251-261.
51. Kee HJ, Hong YH, Kim ER, et al. Effect of enzymatically hydrolyzed alpha-LA fractions with pepsin on growth-promoting of Bifidobacgterium longum ATCC 15707. Korean J Dairy Sci. 1998;20:61-68.
52. Roger LC, Costabile A, Holland DT, et al. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010;156(pt 11):3329-3341.
53. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-67.
54. Le Huerou-Luron I, Blat S, Boudry G. Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev. 2010;23:23-36.
55. Bruck WM, Kelleher SL, Gibson GR, et al. rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr. 2003;37:273-280.
56. Lönnerdal B, Keen CL, Ohtake M, et al. Iron, zinc, copper, and manganese in infant formulas. Am J Dis Child. 1983;137:433-437.
57. Kelleher SL, Chatterton D, Nielsen K, et al. Glycomacropeptide and a-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am J Clin Nutr. 2003;77:1261-1268.
58. Szymlek-Gay EA, Lönnerdal B, Abrams SA, et al. a-Lactalbumin and casein-glycomacropeptide do not affect iron absorption from formula in healthy term infants. J Nutr. 2012;142:1226-1231.
59. Baumy JJ., Brule G. Effect of pH and iconic strength on the binding of bivalent cations to b-casein. Le Lait Dairy Sci Technol. 1988;68:409-417.
60. Wang X, Ai T, Meng XL, et al. In vitro iron absorption of a-lactalbumin hydrolysate-iron and b-lactoglobulin hydrolysate-iron complexes. J Dairy Sci. 2014;97:2559-2566.
61. Szymlek-Gay EA, Domellof M, Hernell O, et al. Mode of oral iron administration and the amount of iron habitually consumed do not affect iron absorption, systemic iron utilisation or zinc absorption in iron-sufficient infants: a randomised trial. Br J Nutr. 2016;116:1046-1060.
62. Layman DK, Anthony TG, Rasmussen BB, et al. Defining meal requirements for protein to optimize metabolic roles of amino acids. Am J Clin Nutr. 2015;101:1330S-1338S.
63. English KL, Mettler JA, Ellison JB, et al. Leucine partially protects muscle mass and function during bed rest in middle-aged adults. Am J Clin Nutr. 2016;103:465-473.
64. Murphy CH, Saddler NI, Devries MC, et al. Leucine supplementation enhances integrative myofibrillar protein synthesis in free-living older men consuming lower- and higher-protein diets: a parallel-group crossover study. Am J Clin Nutr. 2016;104:1594-1606.
65. Fernstrom JD, Wurtman RJ. Brain serotonin content: increase following ingestion of carbohydrate diet. Science. 1971;174:1023-1025.
66. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178:414-416.
67. Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978;30:1531-1538.
68. Markus CR, Olivier B, Panhuysen GE, et al. The bovine protein a-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr. 2000;71:1536-1544.
69. Feurte S, Gerozissis K, Regnault A, et al. Plasma Trp/LNAA ratio increases during chronic ingestion of an alpha-lactalbumin diet in rats. Nutr Neurosci. 2001;4:413-418.
70. Orosco M, Rouch C, Beslot F, et al. Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res. 2004;148:1-10.
71. Choi S, Disilvio B, Fernstrom MH, et al. Meal ingestion, amino acids and brain neurotransmitters: effects of dietary protein source on serotonin and catecholamine synthesis rates. Physiol Behav. 2009;98:156-162.
72. Fernstrom MH, Fernstrom JD. Brain tryptophan concentrations and serotonin synthesis remain responsive to food consumption after the ingestion of sequential meals. Am J Clin Nutr. 1995;61:312-319.
73. Williams WA, Shoaf SE, Hommer D, et al. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem. 1999;72:1641-1647.
74. Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr. 2012;142:2236S-2244S.
75. Lieberman HR, Agarwal S, Fulgoni VL III. Tryptophan intake in the US adult population is not related to liver or kidney function but is associated with depression and sleep outcomes. J Nutr. 2016;146:2609S-2615S.
76. Institute of Medicine. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: National Academies Press; 2006:2-5.
77. Smith B, Prockop DJ. Central-nervous-system effects of ingestion of L-tryptophan by normal subjects. N Engl J Med. 1962;267:1338-1341.
78. Oswald I. Drugs and sleep. Pharmacol Rev. 1968;20:273-303.
79. Jouvet M. Biogenic amines and the states of sleep. Science. 1969;163:32-41.
80. Wyatt RJ, Engelman K, Kupfer DJ, et al. Effects of para-chlorophenylalanine on sleep in man. Electroencephalogr Clin Neurophysiol. 1969;27:529-532.
81. Wyatt RJ, Zarcone V, Engelman K, et al. Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalogr Clin Neurophysiol. 1971;30:505-509.
82. Eccleston D, Ashcroft GW, Crawford TB. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry. 1970;33:269-272.
83. Oswald I, Ashcroft GW, Berger RJ, et al. Some experiments in the chemistry of normal sleep. Br J Psychiatry. 1966;112:391-399.
84. Griffiths WJ, Lester BK, Coulter JD, et al. Tryptophan and sleep in young adults. Psychophysiology. 1972;9:345-356.
85. Schneider-Helmert D. Interval therapy with L-tryptophan in severe chronic insomniacs. A predictive laboratory study. Int Pharmacopsychiatry. 1981;16:162-173.
86. Wyatt RJ, Engelman K, Kupfer DJ, et al. Effects of L-tryptophan (a natural sedative) on human sleep. Lancet. 1970;296:842-846.
87. Bhatti T, Gillin JC, Seifritz E, et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood. Biol Psychiatry. 1998;43:52-59.
88. Markus CR, Jonkman LM, Lammers JH, et al. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr. 2005;81:1026-1033.
89. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 202;47:2336-2348.
90. Srinivasan V, Pandi-Perumal SR, Trahkt I, et al. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci. 2009;119:821-846.
91. Silber BY, Schmitt JA. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev. 2010;34:387-407.
92. Hess SM, Doepfner W. Behavioral effects and brain amine content in rats. Arch Int Pharmacodyn Ther. 1961;134:89-99.
93. Schildkraut JJ. The catecholamine hypothesis of affective disorders. Am J Psychiat. 1965;122:509-522.
94. Jensen K, Fruensgaard K, Ahlfors UG, et al. Letter: tryptophan/imipramine in depression. Lancet. 1975;306:920.
95. Coppen A, Shaw DM, Farrell JP. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet. 1963;281:79-81.
96. Walinder J, Skott A, Carlsson A, et al. Potentiation of the antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry. 1976;33:1384-1389.
97. Pare CM. Potentiation of monoamine-oxidase inhibitors by tryptophan. Lancet. 1963;282:527-528.
98. Cowen PJ. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol Sci. 2008;29:433-436.
99. Glassman AH, Platman SR. Potentiation of a monoamine oxidase inhibitor by tryptophan. J Psychiatr Res. 1969;7:83-88.
100. Rao B, Broadhurst AD. Letter: tryptophan and depression. Br Med J. 1976;1:460.
101. Markus CR, Firk C, Gerhardt C, et al. Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology (Berl). 2008;201:107-114.
102. Kroes MC, van Wingen GA, Wittwer J, et al. Food can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism. Neuroimage. 2014;84:825-832.
103. Scrutton H, Carbonnier A, Cowen PJ, et al. Effects of alpha-lactalbumin on emotional processing in healthy women. J Psychopharmacol. 2007;21:519-524.
104. Merens W, Booij L, Markus R, et al. The effects of a diet enriched with a-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br J Nutr. 2005;94:415-422.
105. Mohajeri MH, Wittwer J, Vargas K, et al. Chronic treatment with a tryptophan-rich protein hydrolysate improves emotional processing, mental energy levels and reaction time in middle-aged women. Br J Nutr. 2015;113:350-365.
106. Engel J. Epilepsy in the world today: medical point of view. Epilepsia. 2002;43(suppl 6):12-13.
107. Bonnycastle DD, Giarman NJ, Paasonen MK. Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol Chemother. 1957;12:228-231.
108. Mainardi P, Leonardi A, Albano C. Potentiation of brain serotonin activity may inhibit seizures, especially in drug-resistant epilepsy. Med Hypotheses. 2008;70:876-879.
109. Meldrum BS, Balzamo E, Wada JA, et al. Effects of L-tryptophan, L-3, 4, dihydroxy-phenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio. Physiol Behav. 1972;9:615-621.
110. Wada JA, Balzamo E, Meldrum BS, et al. Behavioural and electrographic effects of L-5-hydroxytryptophan and D, L-parachlorophenyl-alanine on epileptic Senegalese baboon (Papio papio). Electroencephalogr Clin Neurophysiol. 1972;33:520-526.
111. Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol. 1994;252:105-112.
112. Chadwick D, Trimble M, Jenner P, et al. Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study. Epilepsia. 1978;19:3-10.
113. Ghose KL. Tryptophan in hyperactive child syndrome associated with epilepsy: a controlled study. Neuropsychobiology. 1983;10:111-114.
114. Raotma H. Has tryptophan any anticonvulsive effect? Acta Psychiatr Scand. 1978;57:253-258.
115. Citraro R, Scicchitano F, De Fazio S, et al. Preclinical activity profile of a-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res. 2011;95:60-69.
116. Russo E, Scicchitano F, Citraro R, et al. Protective activity of a-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience. 2012;226:282-288.
117. Fernstrom JD. A perspective on the safety of supplemental tryptophan based on its metabolic fates. J Nutr. 2016;146:2601S-2608S.
118. Stone TW, Stoy N, Darlington LG. An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol Sci. 2013;34:136-143.
119. Toscano CD, Kingsley PJ, Marnett LJ, et al. NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. Neurotoxicology. 2008;29:1114-1120.
120. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:101-197.
121. During MJ, Freese A, Heyes MP, et al. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. FEBS Lett. 1989;247:438-444.
122. Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279:1356-1365.
123. Cross ML, Gill HS. Immunomodulatory properties of milk. Br J Nutr. 2000;84:S81-S89.
124. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489-492.
125. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57:145-155.
126. Choi IY, Lee P, Denney DR, et al. Dairy intake is associated with brain glutathione concentration in older adults. Am J Clin Nutr. 2015;101:287-293.
127. Bounous G, Gervais F, Amer V, et al. The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin Invest Med. 1989;12:343-349.
128. Grey V, Mohammed SR, Smountas AA, et al. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros. 2003;2:195-198.
129. Stipanuk MH, Watford M. Amino acid metabolism. In: Biochemical and Physiological Aspects of Human Nutrition. Stipanuk MH, ed. Philadelphia, PA: WB Saunders; 2000: 233-286.
130. Baker DH. Comparative nutrition and metabolism: explication of open questions with emphasis on protein and amino acids. Proc Nat Acad Sci U S A. 2005;102:17897-17902.
131. McCarty MF, DiNicolantonio JJ. An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly. Age (Dordr). 2015;37:96. doi:10.1007/ s11357-015-9823-8
132. Bounous G, Kongshavn PAL. Influence of dietary proteins on the immune system of mice. J Nutr. 1982;112:1747-1755.
133. Bounous G, Letourneau L, Kongshavn PAL. Influence of dietary protein type on the immune system of mice. J Nutr. 1983;113:1415-1421.
134. Mariotti F, Simbelie KL, Makarios-Lahham K, et al. Acute ingestion of dietary proteins improves post-exercise liver glutathione in rats in a dose-dependent relationship with their cysteine content. J Nutr. 2004;134:128-131.
135. Ford JT, Wong CW, Colditz IG. Effects of dietary protein types on immune respnses and levels of infecion with Eimeria vermiformis in mice. Immunol Cell Biol. 2001;79:23-28.
136. Blouet C, Mariotti F, Mikogami T, et al. Meal cysteine improves postprandial glucose control in rats fed a high-sucrose meal. J Nutr Biochem. 2007;18:519-524.
137. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr. 2002;41:12-18.
138. Micke P, Beeh KM, Schlaak JF, et al. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest. 2001;31:171-178.
139. Agin D, Kotler DP, Papandreou D, et al. Effects of whey protein and resistance exercise on body composition and muscle strength in women with HIV infection. Ann N Y Acad Sci. 2000;904:607-609.
140. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14:542-559.
141. Calder PC, Yaqoob P. Glutamine and the immune system. Amino Acids. 1999;17:227-241.
142. Calder PC. Branched-chain amino acids and immunity. J Nutr. 2006;136:288S-293S.
143. Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Inter Soc Sports Nutr. 2017;17:30-37.
144. Tang JE, Phillips SM. Maximizing muscle protein anabolism: the role of protein quality. Curr Opin Clin Nutr Metab Care. 2009;12:66-71.
145. Groen BB, Res PT, Pennings B, et al. Intragastric protein administration stimulates overnight muscle protein synthesis in elderly men. Am J Physiol Endocrinol Metab. 2012;302:E52-E60.
146. Res PT, Groen B, Pennings B, et al. Protein ingestion before sleep improves post-exercise overnight recovery. Med Sci Sports Exerc. 2012;44:1560-1569.
147. Snijders T, Res PT, Smeets JS, et al. Protein ingestion before sleep increases muscle mass and strength gains during prolonged resistance-type exercise training in healthy young men. J Nutr. 2015;145:1178-1184.
148. Van Cauter E, Plat L, Copinschi G. Interrelations between sleep and the somato-tropic axis. Sleep. 1998;21:553-566.
149. Marliss EB, Aoki TT, Pozefsky T, et al. Muscle and splanchnic glutamine and glutamate metabolism in postabsorptive and starved man. J Clin Invest. 1971;50:814-817.
150. Bassit RA, Sawada LA, Bacurau RFP, et al. Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition. 2002;18:376-379.
151. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-326.
152. Giesbertz P, Daniel H. Branched-chain amino acids as biomarkers in diabetes. Curr Opin Clin Nutr Metab Care. 2016;19:48-54.
153. Knebel B, Strassburger K, Szendroedi J, et al. Specific metabolic profiles and their relationship to insulin resistance in recent-onset type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2016;101:2130-2140.
154. Macotela Y, Emanuelli B, Bang AM, et al. Dietary leucine-an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One. 2011;6:e21187. doi:10.1371/journal.pone.0021187
155. Lackey DE, Lynch CJ, Olson KC, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013;304:E1175-E1187.
156. Devkota S, Layman DK. Protein metabolic roles in treatment of obesity. Curr Opin Clin Nutr Metab Care. 2010;13:403-407.
157. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006;136(1 suppl):319S-323S.
158. Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10:723-736.
159. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448-453.
160. Pedroso JA, Zampieri TT, Donato J Jr. Reviewing the effects of L-leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients. 2015;7:3914-3937.
161. Bounous G, Shenouda N, Kongshavn PAL, et al. Mechanism of altered B-cell response induced by changes in dietary protein type in mice. J Nutr. 1985;115:1409-1417.
162. Mcintoch GH, Regester GO, Le Leu RK, et al. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr. 1995;125:809-816.
163. Hakkak R, Korourian S, Shelnutt SR, et al. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev. 2000;9:113-117.
164. Kent KD, Harper WJ, Bomser JA. Effect of whey proein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol in Vitro. 2003;17:27-33.
165. Ho JCS, Nadeem A, Svanborg C. HAMLET-a protein-lipid complex with broad tumoricidal activity. Biochem Biophys Res Comm. 2017;482:454-458.
166. Rath EM, Duff AP, Hakansson AP, et al. Structure and potential cellular targets of HAMLET-like anti-cancer compounds made from milk components. J Pharm Pharm Sci. 2015;18:773-824.
167. Rammer P, Groth-Pedersen L, Kirkegaard T, et al. BAMLET activates a lysosomal cell death program in cancer cells. Mol Cancer Ther. 2010;9:24-32.
168. Fontana A, Spolaore B, Polverino de Laureto P. The biological activities of protein/oleic acid complexes reside in the fatty acid. Biochim Biophys Acta. 2013;1834:1125-1143.
169. Pettersson J, Mossberg AK, Svanborg C. a-Lactalbumin species variation, HAMLET formation, and tumor cell death. Biochem Biophys Res Comm. 2006;345:260-270.
170. Delgado Y, Morales-Cruz M, Figueroa CM, et al. The cytotoxicity of BAMLET complexes is due to oleic acid and independent of the a-lactalbumin component. FEBS Open Bio. 2015;5:397-404.
171. Nakamura T, Aizawa T, Kariya R, et al. Molecular mechanisms of the cytotoxicity of human a-lactalbumin made lethal to tumor cells (HAMLET) and other protein-oleic acid complexes. J Biol Chem. 2013;288:14408-14416.
172. Bruck WM, Gibson GR, Bruck TB. The effect of proteolysis on the induction of cell death by monomeric alpha-lactalbumin. Biochimie. 2014;97:138-143.
173. Sullivan LM, Kehoe JJ, Barry L, et al. Gastric digestion of a-lactalbumin in adult human subjects using capsule endoscopy and nasogastric tube sampling. Br J Nutr. 2014;112:638-646.
174. Gustafsson L, Leijonhufvud I, Aronsson A, et al. Treatment of skin papillomas with topical a-lacalbumin-oleic acid. N Engl J Med. 2004;350:2663-2672.
175. Mossberg AK, Wullt B, Gustafsson L, et al. Bladder cancers respond to intravesical instillation of HAMLET (human a-lactalbumin made lethal to tumor cells). Int J Cancer. 2007;121:1352-1359.
176. Mossberg AK, Hou Y, Svensson M, et al. HAMLET treatment delays bladder cancer development. J Urol. 2010;183:1590-1597.
177. Fischer W, Gustafsson L, Mossberg AK, et al. Human a-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brian xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res. 2004;64:2105-2112.
178. Puthia M, Storm P, Nadeem A, et al. Prevention and treatment of colon cancer by peroral administratioin of HAMLET (human a-lactalbumin made lethal to tu-mour cells). Gut. 2013;63:131-142.